Terns Pharmaceuticals, Inc. — All Filings
398 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC14D9C
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002421 | Mar 27, 2026 | — |
| SC TO-C | SC TO-C | 0001193125-26-124741 | Mar 26, 2026 | — |
| SC14D9C | SC14D9C | 0001193125-26-124334 | Mar 25, 2026 | — |
| SC TO-C | SC TO-C | 0001193125-26-124269 | Mar 25, 2026 | — |
| SC14D9C | SC14D9C | 0001193125-26-122823 | Mar 25, 2026 | — |
| SC TO-C | SC TO-C | 0001193125-26-122803 | Mar 25, 2026 | — |
| 8-K | 8-K | 0001193125-26-122785 | Mar 25, 2026 | Mar 24, 2026 |
| 4 | PRIMARY DOCUMENT | 0001872564-26-000008 | Mar 17, 2026 | Mar 16, 2026 |
| 4 | PRIMARY DOCUMENT | 0001872564-26-000006 | Feb 18, 2026 | Feb 17, 2026 |
| SCHEDULE 13G/A | — | 0001831942-26-000009 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001213900-26-016651 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0001172661-26-000722 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0001213900-26-015655 | Feb 12, 2026 | — |
| SCHEDULE 13G | — | 0000902664-26-000916 | Feb 12, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0001403571-26-000002 | Feb 2, 2026 | Feb 1, 2026 |
| 4 | PRIMARY DOCUMENT | 0001761114-26-000002 | Feb 2, 2026 | Feb 1, 2026 |
| 4 | PRIMARY DOCUMENT | 0001656998-26-000002 | Feb 2, 2026 | Feb 1, 2026 |
| 4 | PRIMARY DOCUMENT | 0001799780-26-000002 | Feb 2, 2026 | Feb 1, 2026 |
| 4 | PRIMARY DOCUMENT | 0001174454-26-000003 | Feb 2, 2026 | Feb 1, 2026 |
| 4 | PRIMARY DOCUMENT | 0001041126-26-000002 | Feb 2, 2026 | Feb 1, 2026 |
| 8-K | 8-K | 0001193125-26-019426 | Jan 22, 2026 | Jan 16, 2026 |
| 4 | PRIMARY DOCUMENT | 0001892413-26-000004 | Jan 16, 2026 | Jan 14, 2026 |
| 4 | PRIMARY DOCUMENT | 0001563623-26-000002 | Jan 16, 2026 | Jan 14, 2026 |
| 4 | PRIMARY DOCUMENT | 0001872564-26-000004 | Jan 16, 2026 | Jan 14, 2026 |
| 144 | — | 0001950047-26-000467 | Jan 15, 2026 | — |
| 8-K | 8-K | 0001193125-26-008907 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | PRIMARY DOCUMENT | 0001872564-26-000002 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | PRIMARY DOCUMENT | 0001892413-26-000002 | Jan 6, 2026 | Jan 2, 2026 |
| 8-K | 8-K | 0001193125-25-315065 | Dec 11, 2025 | Dec 9, 2025 |
| 424B5 | 424B5 | 0001193125-25-315064 | Dec 11, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-311951 | Dec 9, 2025 | — |
| S-3ASR | S-3ASR | 0001193125-25-311847 | Dec 9, 2025 | — |
| 8-K | 8-K | 0001193125-25-311202 | Dec 8, 2025 | — |
| SCHEDULE 13G/A | — | 0001831942-25-000027 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-274367 | Nov 10, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-274282 | Nov 10, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001799780-25-000004 | Nov 5, 2025 | Nov 4, 2025 |
| SCHEDULE 13D/A | — | 0000947871-25-000950 | Nov 5, 2025 | — |
| 144 | — | 0001950047-25-008447 | Nov 4, 2025 | — |
| 8-K | 8-K | 0001193125-25-261798 | Nov 3, 2025 | — |
| SCHEDULE 13G | — | 0000102909-25-000325 | Oct 31, 2025 | — |
| 8-K | 8-K | 0001193125-25-245404 | Oct 22, 2025 | Oct 21, 2025 |
| 4 | PRIMARY DOCUMENT | 0001892413-25-000004 | Oct 2, 2025 | Oct 1, 2025 |
| SCHEDULE 13G | — | 0001831942-25-000019 | Sep 16, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-003270 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-103124 | Aug 5, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-103071 | Aug 5, 2025 | — |
| 4 | PRIMARY DOCUMENT | 0001562180-25-005308 | Jul 3, 2025 | Jul 1, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-005120 | Jun 30, 2025 | Jun 27, 2025 |
| 4 | PRIMARY DOCUMENT | 0001562180-25-005077 | Jun 25, 2025 | — |